1. Home
  2. TBBK vs RCKT Comparison

TBBK vs RCKT Comparison

Compare TBBK & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBBK
  • RCKT
  • Stock Information
  • Founded
  • TBBK 1999
  • RCKT 1999
  • Country
  • TBBK United States
  • RCKT United States
  • Employees
  • TBBK N/A
  • RCKT N/A
  • Industry
  • TBBK Major Banks
  • RCKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TBBK Finance
  • RCKT Health Care
  • Exchange
  • TBBK Nasdaq
  • RCKT Nasdaq
  • Market Cap
  • TBBK 2.7B
  • RCKT 1.9B
  • IPO Year
  • TBBK 2004
  • RCKT N/A
  • Fundamental
  • Price
  • TBBK $50.51
  • RCKT $17.13
  • Analyst Decision
  • TBBK Buy
  • RCKT Strong Buy
  • Analyst Count
  • TBBK 3
  • RCKT 9
  • Target Price
  • TBBK $55.00
  • RCKT $53.22
  • AVG Volume (30 Days)
  • TBBK 564.7K
  • RCKT 731.3K
  • Earning Date
  • TBBK 10-24-2024
  • RCKT 11-04-2024
  • Dividend Yield
  • TBBK N/A
  • RCKT N/A
  • EPS Growth
  • TBBK 16.52
  • RCKT N/A
  • EPS
  • TBBK 3.95
  • RCKT N/A
  • Revenue
  • TBBK $472,015,000.00
  • RCKT N/A
  • Revenue This Year
  • TBBK N/A
  • RCKT N/A
  • Revenue Next Year
  • TBBK $7.05
  • RCKT $300.20
  • P/E Ratio
  • TBBK $12.71
  • RCKT N/A
  • Revenue Growth
  • TBBK 6.71
  • RCKT N/A
  • 52 Week Low
  • TBBK $29.92
  • RCKT $15.98
  • 52 Week High
  • TBBK $59.26
  • RCKT $32.53
  • Technical
  • Relative Strength Index (RSI)
  • TBBK 44.27
  • RCKT 46.41
  • Support Level
  • TBBK $45.82
  • RCKT $17.05
  • Resistance Level
  • TBBK $59.26
  • RCKT $17.75
  • Average True Range (ATR)
  • TBBK 2.17
  • RCKT 0.72
  • MACD
  • TBBK -0.96
  • RCKT 0.06
  • Stochastic Oscillator
  • TBBK 35.86
  • RCKT 40.23

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Share on Social Networks: